[1] Uttley L, Carroll C, Wong R, Hilton DA, Stevenson M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis 2020;20(1):E2 − 10. https://doi.org/10.1016/S1473-3099(19)30615-2.
[2] Zerr I, Ladogana A, Mead S, Hermann P, Forloni G, Appleby BS. Creutzfeldt-Jakob disease and other prion diseases. Nat Rev Dis Primers 2024;10(1):14. https://doi.org/10.1038/s41572-024-00497-y.
[3] Baiardi S, Mammana A, Capellari S, Parchi P. Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies. Expert Opin Ther Targets 2023;27(12):1271 − 84. https://doi.org/10.1080/14728222.2023.2199923.
[4] Nakagaki T, Ishibashi D, Mori T, Miyazaki Y, Takatsuki H, Tange H, et al. Administration of FK506 from late stage of disease prolongs survival of human prion-inoculated mice. Neurotherapeutics 2020;17(4):1850 − 60. https://doi.org/10.1007/s13311-020-00870-1.
[5] Shi Q, Chen C, Xiao K, Zhou W, Gao C, Gao LP, et al. Characteristics of different types of prion diseases - China’s surveillance. China CDC Wkly 2022;4(33):723 − 8. https://doi.org/10.46234/ccdcw2022.151.
[6] Denouel A, Brandel JP, Seilhean D, Laplanche JL, Elbaz A, Haik S. The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis. Eur J Epidemiol 2023;38(7):757 − 64. https://doi.org/10.1007/s10654-023-01004-5.
[7] Park HY, Suh CH, Shim WH, Kim SO, Kim WS, Jeong S, et al. Prognostic value of diffusion-weighted imaging in patients with newly diagnosed sporadic Creutzfeldt-Jakob disease. Eur Radiol 2022;32(3):1941 − 50. https://doi.org/10.1007/s00330-021-08363-1.
[8] Iwasaki Y, Akagi A, Mimuro M, Kitamoto T, Yoshida M. Factors influencing the survival period in Japanese patients with sporadic Creutzfeldt-Jakob disease. J Neurol Sci 2015;357(1-2):63 − 8. https://doi.org/10.1016/j.jns.2015.06.065.
[9] Staffaroni AM, Kramer AO, Casey M, Kang HC, Rojas JC, OrrúCD, et al. Association of blood and cerebrospinal fluid tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease. JAMA Neurol 2019;76(8):969 − 77. https://doi.org/10.1001/jamaneurol.2019.1071.
[10] Karch A, Raddatz LM, Ponto C, Hermann P, Summers D, Zerr I. Diagnostic profiles of patients with late-onset Creutzfeldt-Jakob disease differ from those of younger Creutzfeldt-Jakob patients: a historical cohort study using data from the German National Reference Center. J Neurol 2014;261(5):877 − 83. https://doi.org/10.1007/s00415-014-7283-1.
[11] McNiven K, Nihat A, Mok TH, Tesfamichael S, O’Donnell V, Rudge P, et al. Enteral feeding is associated with longer survival in the advanced stages of prion disease. Brain Commun 2019;1(1):fcz012. https://doi.org/10.1093/braincomms/fcz012.